Book II: Medical devices, in vitro diagnostic medical devices and other products and articles regulated in the interests of public health

Any portable device for listening to sound through a listening device and any listening device placed on the market, held for sale, sold or distributed free of charge are designed to be safe for the user’s hearing under normal or reasonably foreseeable conditions of use. These portable devices are accompanied by health messages on the risks associated with their use and on how to prevent these risks. Portable equipment and…

All advertising, by whatever means or on whatever medium, promoting the use of mobile telephones for voice communications must clearly, visibly and legibly state the recommended use of a listening device to limit exposure of the head to radio emissions from the equipment. The listening device used to limit exposure of the head to the electromagnetic fields emitted by the equipment must also appear on this advertisement. Offenders are liable…

The obligations imposed on operators of restaurants, public houses and other establishments where food or drink is served to the public regarding the cleaning after use of utensils used by the said establishments, as well as the obligations imposed on hairdressers, manicurists, chiropodists, masseurs and all other professionals providing personal care, regarding the cleaning of objects used either in the place where they exercise their profession or on their customers’…

Service providers and distributors of equipment, including medical devices or their accessories, designed to help people who are ill or have an incapacity or disability within the meaning of article L. 114 of the French Social Action and Family Code to return to their own homes and become independent, must have staff who hold a diploma, validated professional experience or equivalent attesting to training in the provision of this equipment…

Healthcare professionals who use the healthcare products mentioned in 18° to 20° of Article L. 5311-1 shall report without delay to the Agence nationale de sécurité du médicament et des produits de santé any incident involving these products likely to have adverse effects on people’s health. The procedures for applying this article are determined by decree in the Conseil d’Etat.

I.-Any person who places on the market products which, at the end of their manufacturing process, contain substances whose endocrine-disrupting properties the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (French National Agency for Food, Environmental and Occupational Health Safety) describes as known or suspected shall make available to the public electronically, in an open format that can be easily re-used and exploited by an automated…